Richter-Helm

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Subsection - Oncology

Essential DMPK Strategies for IND Success

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

GERMAN RELIABILITY AND THOROUGHNESS

Richter-Helm is a Hamburg, Germany-based contract development and manufacturing company specialized in products derived from bacteria and yeasts, with a proven 30-year track record.

Count on us to flexibly provide a comprehensive range of services and customized solutions. Clients worldwide have already benefited from our commitment to good manufacturing practice and total transparency. Our work focuses on recombinant proteins, plasmid DNA, antibody fragments, and vaccines.

Our seasoned, 190-strong team supports you with process development, supply of products for clinical trials, commercial production, in-house QC testing, and QP release. We operate two GMP-compliant production plants with bioreactor capacities of up to 1500 liters.

Richter-Helm consistently works to the highest standards of pharmaceutical quality. This has been verified by major regulatory bodies including EMA, FDA, Pmda, ANVISA, and MFDS as well as by numerous customer audits.

In addition Richter-Helm is the platform of its mother companies Gedeon Richter and Helm AG for worldwide licensing options as well as partnerships for co-development and marketing of microbial derived biopharmaceutical projects.